Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma. - Jin N; Keam B; Cho J; Lee MJ; Kim HR; Torosyan H; Jura N; Ng PK; Mills GB; Li H; Zeng Y; Barbash Z; et al. (The Journal of clinical investigation, 2021)